The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C-3 modified analogues

Procopiou, Panayiotis A, Cox, Brian, Kirk, Barrie E, Lester, Michael G, McCarthy, Alun D, Sareen, Meenu, Sharratt, Peter J, Snowden, Michael A, Spooner, Stephen J, Watson, Nigel S and Widdowson, Julia (1996) The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C-3 modified analogues. Journal of Medicinal Chemistry, 39 (7). pp. 1413-1422. ISSN 0022-2623

Full text not available from this repository.

Abstract

Squalestatin analogues modified at C3 were prepared and evaluated for their ability to inhibit rat liver microsomal squalene synthase in vitro. While the 4,6-dimethyloctenoate ester group at C6 was maintained, a number of modifications to the C3 carboxylic acid were well tolerated. However, in the absence of the C6 ester group, similar modifications to the C3 carboxyl group caused loss of activity. Selected compounds were evaluated for their ability to inhibit cholesterol biosynthesis in vivo in rats 1 and 6 h postadministration. Analogues of squalestatin 1 (S1) modified at C3 were found to possess a shorter duration of effect in vivo which is reflected in their substantially reduced ability to lower serum cholesterol levels in marmosets. Significant cholesterol lowering (up to 62%) for the C3 hydroxymethyl analogue 1b was observed only when this compound was dosed three times a day for 3 days.

Item Type: Article
Schools and Departments: School of Life Sciences > Chemistry
Subjects: Q Science > QD Chemistry
Depositing User: Tom Gittoes
Date Deposited: 13 Jan 2015 15:18
Last Modified: 13 Jan 2015 15:18
URI: http://sro.sussex.ac.uk/id/eprint/52100
📧 Request an update